Kedokteran & Kesehatan editorial
Open AccessOA2019
Multidrug-Resistant Tuberculosis (MDR-TB): Epidemiology, Causes, Pathophysiology, Diagnostic Approaches, Preventive Interventions, and Treatment Challenges/Opportunities โ (An Evidence-Based Narrative Literature Review)
This narrative review synthesizes evidence on the epidemiology, causes, pathophysiology, diagnostics, prevention, and treatment challenges of multidrug-resistant tuberculosis (MDR-TB). It advocates for improved investigation and multidisciplinary coordination to enhance therapeutic outcomes.
Khalid Rahmanยท Texila international journal of clinical researchยท 2019ยท DOI 10.21522/tijcr.2014.06.01.art003
The core problem
Multidrug-resistant tuberculosis (MDR-TB) is described as one of the greatest global public health issues. The mutation tendency of *Mycobacterium tuberculosis* substantially elevates its resistance against recommended pharmacotherapeutic interventions. Limited information on MDR-TB diagnostic approaches and treatment options is primarily responsible for its extensive progression across resource-limited regions. Furthermore, the frequently reported adverse effects of standard therapies barricade their long-term use by MDR-TB patients. The presented narrative review attempts to consolidate and strengthen the clinical evidence for improving MDR-TB diagnosis and treatment decisions in healthcare settings.
Innovation
The author performed an evidence-based analysis of the causative factors, pathophysiology, diagnostic techniques, and treatment options/challenges for MDR-TB through the systematic exploration of databases including Google Scholar, PubMed/Medline, and Cochrane Library. The utilization of these databases was effectively undertaken to explore peer-reviewed MDR-TB-related articles based on meta-analysis, systematic review, retrospective study, randomized controlled trial, and narrative literature reviews.
Introduction
Multidrug-resistant tuberculosis (MDR-TB) is described as one of the greatest global public health issues. The mutation tendency of *Mycobacterium tuberculosis* substantially elevates its resistance against recommended pharmacotherapeutic interventions. Limited information on MDR-TB diagnostic approaches and treatment options is primarily responsible for its extensive progression across resource-limited regions. Furthermore, the frequently reported adverse effects of standard therapies barricade their long-term use by MDR-TB patients. The presented narrative review attempts to consolidate and strengthen the clinical evidence for improving MDR-TB diagnosis and treatment decisions in healthcare settings.
Why it matters
The study findings advocate the need for improving the overall MDR-TB investigation and treatment process to control the elevated prevalence of MDR-TB among suspected patients. The study outcomes advocate the requirement of multidisciplinary coordination between clinicians and researchers to effectively improve the medical decision-making quality for enhancing the therapeutic outcomes of MDR-TB patients.
Who should read this
Pembaca Research Digest dan praktisi rumpun ini.
Opening member contentโฆ